We envisage that hyperbaric oxygen (HBO) would ameliorate islet anoxia, preventing early graft failure. Thus, treatment of HBO to diabetic recipients should improve the outcome of islet transplantation. We tested this hypothesis by syngeneically transplanting insufficient number of islets (150 islets) into streptozotocindiabetic C57BL/6 mice, each followed by HBO (2.4 ATA, 100% O 2 ) therapy for 1.5 h from day 0 to 28, once daily (group A) or twice daily (group B), or from day 5 to 28, once daily (group C) or twice daily (group D), 6 days/week. Recipients without HBO treatment served as controls. At day 28 after transplantation, groups B, C, and D gained weight and had lower blood glucose compared with their baseline values. In addition, groups B and D had higher insulin content of the graft than the controls. To determine the optimal timing of HBO therapy, groups B and D were compared with recipients treated with HBO twice daily, 6 days/week, from day −14 to 0 (group E) and from day −14 to 28 (group F). At day 28 after transplantation, groups B, D, E, and F had significantly lower blood glucose than their individual baseline values and higher insulin content of the graft than controls. But only group F had more β-cell mass of the graft than controls. These findings lend credence to the expectation that peritransplant application of adequate frequency of HBO to diabetic recipients would enhance the performance and growth of the islet graft, resulting in an improvement of the outcome of the transplantation.
INTRODUCTION
of engraftment, which could decrease the effective β-cell mass and contribute to the early graft failure (2). In vivo, islets have a high metabolic rate and are richly vascular- (17) . This improves the cellular oxygen supply by rais-MATERIALS AND METHODS ing the tissue-cellular diffusion gradient. In addition, Animals HBO can promote the formation of the collagen matrix Male inbred C57BL/6 mice were used as donors and and angiogenesis in irradiated tissue, and inhibit neutrorecipients for transplantation. The recipients, aged 8-12 phil adherence and avoid postischemic vasoconstriction weeks, were made diabetic by a single IP injection of in ischemic tissue (26) . On the basis of these observastreptozotocin (Sigma Immunochemicals, St. Louis, MO, tions, it is reasonable to envisage that HBO would in-200 mg/kg body weight, freshly dissolved in citrate crease the oxygenation and/or neovascularization of islet buffer, pH 4.5). Before transplantation, diabetes was grafts. In so doing, islet anoxia would be ameliorated confirmed by the presence of hyperglycemia, weight and early graft failure prevented. In this study we examloss, and polyuria. Only those mice with a blood glucose ined the efficacy of HBO on islet transplantation and the level higher than 19.4 mmol/L were transplanted at 14 optimal condition for HBO therapy.
Figure 1.
Changes of blood glucose (upper panel) and percent body weight (lower panel) in recipients without HBO (n = 7, ᮀ), with HBO therapy, twice daily, from day 0 to day 28, once daily (n = 5, ᭺) or twice daily (n = 14, G), or from day 5 to day 28 once daily (n = 6, ᭝) or twice daily (n = 5, L) after transplantation. Values are mean ± SE. *p < 0.05, +p < 0.01, §p < 0.001 vs. data at the day of transplantation. rated by a density gradient (Histopaque-1077; Sigma Immunochemicals) and these purified islets were then handpicked under a dissecting microscope. Islets >75 and <250 µm in diameter were collected and carefully counted into sets of 150 islets.
One hundred and fifty islets were syngeneically transplanted under the left kidney capsule of streptozotocin-diabetic recipients on the same day as the isolation. To accomplish this, the islets were centrifugated in PE-50 tubing (Clay Adams, Parsippany, NJ) connected to a 200-µl pipette tip. With the mouse under amobarbital anesthesia, the left kidney was exposed through a lumbar incision. A capsulotomy was performed in the lower pole of the kidney and the tip of the tubing advanced under the capsule of the upper pole, the site of final injection. The capsulotomy was left unsutured. After transplantation, recipients' blood glucose and body weight were measured twice a week in the first 2 weeks and then once a week. Normoglycemia was defined as nonfasting blood glucose levels <11.1 mmol/L.
HBO Therapy
To determine the adequate frequency of HBO therapy, recipients were put into an HBO chamber (2.4 ATA, 100% O 2 ) (26) for 1.5 h from day 0 to 28, once daily (group A) or twice daily (group B), or from day 5 to 28, once daily (group C) or twice daily (group D), 6 days/week, after transplantation. To determine the optimal timing of HBO therapy, groups B and D were compared with recipients receiving HBO treatment twice daily, 6 days/week, from day −14 to 0 (group E) and After an overnight fast, glucose was injected IP as a 5% glucose solution (1.5 g/kg) and blood glucose was measured at 0, 30, 60, 90, and 120 min by tail snipping. The area under the curve was calculated as the sum of days after streptozotocin injection. Blood was obtained blood glucose values during the test (6-14). from the snipped tail, and glucose was measured with a portable glucose meter (One Touch II, Lifescan Inc., Glycated Hemoglobin (HbA 1c ) Milpitas, CA). The animals were kept under conven-Blood was obtained from the snipped tail, and HbA 1c tional conditions with free access to tap water and stanwas measured by DCA2000 (Bayer Diagnostics, Elkdard pelleted food. hart, IN).
Islet Isolation and Transplantation
Immunohistochemistry The method we used has been previously described (7-13). Under anesthesia with sodium amobarbital
The removed grafts were fixed in formalin solution and processed for paraffin embedding, sectioning, and (amytal sodium; Lilly, Indianapolis, IN), pancreases were distended with 2.5 ml of RPMI-1640 medium immunoperoxidase staining. Sections of grafts were stained for the endocrine non-β-cells with immunoper-(Gibco BRL, Grand Island, NY) containing 1.5 mg/ml of collagenase (collagenase from Clostridium histolyti-oxidase. Staining for the endocrine non-β-cells was done with a cocktail of antibodies: rabbit anti-bovine glucacum, type XI, Sigma Immunochemicals), excised, and incubated in a water bath at 37°C. The islets were sepa-gon, rabbit anti-human somatostatin, and rabbit anti-human pancreatic polypeptide (Dako Co., Ltd, Japan). We stained by intercepts over total tissue, then the β-cell mass was estimated by multiplying β-cell relative volume by graft the endocrine non-β-cells instead of the β-cells because β-cell degranuation, which is associated with chronic weight. hyperglycemia, results in a weak or negative staining of Insulin Content β-cells.
The removed graft-bearing kidneys were homogeβ-Cell Mass nized in acid ethanol. After homogenization, the samples were extracted overnight at 4°C. On the following day, The method used for measurement of the β-cell mass has previously been described in detail (6,8,13). It was they were centrifuged at 2400 rpm for 30 min and the supernatant was stored at −20°C. The pellet was again measured by point counting morphometry on sections of grafts stained for the endocrine non-β-cells. Each sec-homogenized in acid ethanol and insulin was extracted overnight. After centrifugation, this second supernatant tion was covered systematically using a 48-point grid to obtain the number of intercepts over β-cells, endocrine was added to the first extraction sample. Insulin was measured by radioimmunoassay with INSI-PR kit (CIS non-β-cells, and other tissue. The β-cell relative volume was calculated by dividing the intercepts over β-cells US Inc., Bedford, MA). Statistical Analysis −4.43 ± 1.32, and −9.33 ± 1.52 mmol/L, respectively (p < 0.05 between group B and control). In addition, groups Results were expressed as mean ± SE. For compari-B and D had abundant β-cells (Fig. 2) and higher insulin sons between two groups, the paired or unpaired Stucontent of the graft (7.75 ± 1.65 and 8.85 ± 1.30 µg, redent's t-test (two-tailed) was used, and for multiple comspectively) than the controls (2.40 ± 0.39 µg) (p < 0.05). parisons, the one-way ANOVA was employed. A value But the insulin content of the graft in group A (2.76 ± of p < 0.05 was considered significant.
1.29 µg) and group C (4.40 ± 0.87 µg) was similar to RESULTS that in the controls. At days 3 and 5, under the dissecting microscope, Adequate Frequency of HBO Therapy there was no new vessel formation noted on the grafts The blood glucose levels of groups B, C, and D deof the recipients in group B (n = 3). creased after transplantation and, at day 28, these groups gained weight and had lower blood glucose compared Optimal Timing of HBO Therapy with their baseline values (Fig. 1) . In contrast, group A and the controls remained severely hyperglycemic and After transplantation, the blood glucose levels of groups B, D, E, and F decreased and group F achieved had no weight gain (Fig. 1) . At day 28, the change of blood glucose levels in the controls and groups A, B, normoglycemia at day 21 (Fig. 3) . At day 28, these groups had significantly lower blood glucose than their C, and D was 0.13 ± 2.48, −1.71 ± 4.02, −9.75 ± 1.63, Controls 7.6 ± 0.4 (n = 11) 87.2 ± 6.5 (n = 19) 0.11 ± 0.04 (n = 5) 3.00 ± 1.10 (n = 8) B
7.5 ± 0.6 (n = 6) 52.9 ± 5.5* (n = 7) 0.24 ± 0.03 (n = 5) 7.75 ± 1.65* (n = 11) D 7.1 ± 0.7 (n = 7) 49.9 ± 6.7* (n = 8) 0.17 ± 0.02 (n = 5) 8.85 ± 1.30* (n = 5) E 6.8 ± 0.7 (n = 5) 66.6 ± 9.8 (n = 5) 0.08 ± 0.02 (n = 5) 8.45 ± 2.15* (n = 5) F 6.4 ± 0.3 (n = 10) 41.3 ± 4.3* (n = 8) 0.33 ± 0.09* (n = 5) 13.75 ± 2.65* (n = 5)
Values are mean ± SE. The recipients treated with hyperbaric oxygen (HBO) twice daily, 6 days/week, from day 0 to day 28 (group B), day 5 to day 28 (group D), day −14 to day 0 (group E), and day −14 to day 28 (group F) after transplantation. Recipients without HBO treatment served as controls. AUC: area under the curve during the IP glucose tolerance test; HbA 1c : glycated hemoglobin. *p < 0.05 vs. controls.
individual baseline values (Fig. 3) . Groups B, D, and F mic and 3/8 died (data not shown). It is evident that HBO alone cannot have a beneficial effect. Therefore, also gained weight ( Fig. 3) and had better glucose tolerance ( Fig. 4 , Table 1 ) than controls at day 28. However, we recommend treating diabetic recipients with HBO, 2.4 ATA, 100% O 2 , twice daily, ranging from 14 days their HbA 1c values were comparable to that of controls (Table 1 ). The change of blood glucose levels in groups before transplantation to 28 days after. The mechanism(s) by which HBO therapy enhances E and F was −6.55 ± 2.19 and −15.72 ± 1.57 mmol/L, respectively. The graft of groups B, D, E, and F con-the performance of transplanted islets is not known. It can be attributed to the increase in graft oxygenation tained higher insulin content, but only group F had more β-cell mass of the graft than that of the controls (Table 1) . and/or neovascularization. However, the absence of early neovascularization in grafts of the HBO-treated re-DISCUSSION cipients suggests that the effect of HBO is unlikely that of stimulating new vessel formation in the graft. Rather, HBO therapy has long been applied in the treatment of respiratory disease, underwater diving accidents, de-it is possible that the beneficial effects of HBO therapy contribute by increasing graft oxygenation. compression sickness, and air embolisms. By forcing oxygen into body fluids and tissues, this process has
In summary, with the dose of 2.4 ATA, 100% O 2 for 1.5 h twice daily, peritransplant HBO treatment to the been shown to increase tissue oxygenation and induce tissue neovascularization (17, 26) . The application of recipients is beneficial for the overall performance of islet grafts and outcome of transplantation. We find this HBO to transplantation has been previously reported to accelerate the union of rabbit autogenous free bone approach informative, and extension of this finding to a clinical setting for humans requires further studies. grafts (22) and prolong mouse thyroid allograft survival following organ culture (25). However, Hullett et al.
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showed no improvement over control for the time graft experiments, when human fetal pancreas cultured with or without HBO was used (5). In contrast, using REFERENCES adult islets for transplantation and in vivo HBO treat-
